Jean-Yves Courtial

Thanks to cost cuts, Dolfines "limits" the impact of declining sales

The company, which specializes in engineering and services for the renewable and conventional energy industries, unveiled its first-half results, marked by tighter cost controls and a return to profitability during the first four months of the second half.

October 28, 2026 at 01:32 pm

Growth Confirmed for Groupe Crit in the Third Quarter

In an uncertain macroeconomic environment, the temporary employment specialist posted consolidated revenue of €885.1m in the third quarter, representing entirely organic growth of 2% compared with the same period of the previous fiscal year.

October 28, 2026 at 01:18 pm

Vetoquinol's acceleration continued in the third quarter

The animal health specialist posted revenue of €139.7m in the third quarter, up 10.4%. The period benefited from a positive foreign-exchange impact of €1m from the United States and the Americas excluding the US, as well as a favorable comparison base.

October 28, 2026 at 01:06 pm

Acteos on the right track after first-half improvements

In the first half of 2026, the software publisher specializing in supply chain optimization saw tangible benefits from its strategic refocusing on its core business.

October 28, 2026 at 12:59 pm

€149m contract for Vinci in Poland

The city of Warsaw has awarded Warbud, the local subsidiary of Vinci Construction, the contract for the second phase of construction of the future Sinfonia Varsovia symphony orchestra complex. The total value of the project is €149m, with completion scheduled for 2030.

October 28, 2026 at 12:56 pm

GE Healthcare very healthy indeed after solid quarterly results and raised guidance

The provider of healthcare solutions in medical technology and pharmaceutical diagnostics (+8.19%, to $76.88) posted Q3 results above its own expectations, both in terms of activity and profitability. The group took the opportunity to raise its full-year guidance.

October 28, 2026 at 11:46 am

Genmab surges after clinical success in head and neck cancer

The biotechnology company's shares are jumping over 23% to about 3,700 Danish kronor after announcing highly positive preliminary results from a global Phase 3 trial. The study is evaluating Petosemtamab, an investigational bispecific antibody, in combination with Pembrolizumab as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) expressing PD-L1.

October 28, 2026 at 11:22 am

Jefferies maintains Buy rating on Stellantis, stock soars

Stellantis stands out at the top of the CAC 40 (+12%, at over EUR4.1 this afternoon) after its quarterly trading update. The group posted a reduction in its losses and confirmed all of its full-year financial targets.

October 28, 2026 at 10:21 am

Diabetes and obesity: Eli Lilly's Retatrutide outperforms Ozempic in Phase 3

The US pharma giant has reached a clinical and commercial milestone in the highly contested incretin market. The pharmaceutical group unveiled positive Phase 3 results from a head-to-head trial evaluating Retatrutide against Novo Nordisk's injectable Ozempic (2 mg) in adults with type 2 diabetes.

October 28, 2026 at 10:14 am

Symrise stumbles as outlook comes under scrutiny

Symrise shares are plunging on the Frankfurt Stock Exchange (-9.36%, to EUR90.68), one of the sharpest fallers in the Stoxx Europe 600. The company, which develops, produces and markets fragrances, flavors and functional ingredients, nevertheless reported stronger-than-expected growth in Q3, although its outlook disappointed.

October 28, 2026 at 06:06 am

Prodways to sell its Materials business

The 3D printing specialist is continuing to refocus its operations and announced that it has signed an agreement to sell its Materials division, operated by its DeltaMed subsidiary, to a group specializing in the dental sector.

October 28, 2026 at 04:10 am

TotalEnergies strengthens partnership with Chevron and supports its employees

French energy giant accelerates investment in the Gulf of Mexico. The company announced the acquisition of a 25% stake in 26 exploration licenses operated by US group Chevron off the coast of the United States.

October 28, 2026 at 03:43 am

Assystem fine-tunes targets after nuclear-backed results

The engineering group reported consolidated revenue of €492.1m for the first nine months of the year, up 1.7%, or 2.8% on an organic basis. Activity accelerated in the third quarter, rising 3.7%, or 3.4% organically, to €163.6m.

October 27, 2026 at 12:49 pm

Analysts react to Mercedes-Benz Group's profit warning

The German giant's stock is down sharply in Frankfurt (-3.7%, at about EUR40) after the group cut some of its full-year financial targets due to an increasingly difficult market environment in China and rising costs in Q4.

October 27, 2026 at 11:10 am

HCA Healthcare: Quarterly Revenue Up, but Net Income Down

In Q3, the US hospital operator posted revenue of $19.849bn, up 3.6% from $19.161bn generated in the same period a year earlier.

October 27, 2026 at 11:08 am

Pfizer announces phase 3 success for Elrexfio

The US drugmaker has unveiled positive topline results from a phase 3 clinical trial evaluating Elrexfio as a monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who had previously received at least one line of treatment, including anti-CD38 therapy (daratumumab or isatuximab) and lenalidomide.

October 27, 2026 at 11:06 am

BASF Expands Production Capacity in the US

German chemical giant BASF has inaugurated an expansion of its alkyl polyglucoside (APG) production capacity at its Cincinnati, Ohio, site. Announced in 2023, the investment is intended to strengthen the company's position as a leading APG supplier in the US market while reinforcing its industrial footprint in North America and the agility of its global network.

October 27, 2026 at 09:55 am

Airbus wins contract for two additional second-generation Galileo satellites

The European Space Agency (ESA), acting on behalf of the European Union Agency for the Space Programme (EUSPA) under delegation from the European Commission, has awarded Airbus a contract to build two new second-generation Galileo satellites (G2). The order follows an earlier contract for six G2 satellites and will capitalize on the manufacturer's existing industrial capabilities.

October 27, 2026 at 06:36 am

Mercedes-Benz in reverse after another profit warning

The German automaker (stock -3.75%, at EUR39.76) has lowered its financial outlook for FY 2026. The group attributed the adjustment to an increasingly difficult market environment in China, as well as higher expected costs in the final three months of the year, particularly for materials.

October 27, 2026 at 06:29 am

Stifel notes a third quarter below expectations for Lumibird

The European laser technology specialist (-4.78%, to €22.90) reported consolidated revenue of €168.8m for the first nine months of fiscal 2026, up 8.8% (+10.3% at constant exchange rates and scope). Activity accelerated sharply in the third quarter alone, posting 12% growth.

October 27, 2026 at 06:15 am

Higher profitability and cash flow for Porsche AG

In the first nine months of FY 2026, Porsche AG reported revenue of EUR25.28bn, down 5.9% from EUR26.86bn in 9m 2025. The decline in revenue was significantly more contained than the drop in deliveries, which fell 16% to 178,532 units, reflecting the implementation of the "Value over Volume" strategy focused on higher-margin models and a favorable product mix.

October 27, 2026 at 04:20 am